Searching journal content for somatostatin analogs (as phrase) in full text.

Displaying results 1-10 of 111
For checked items
  1. ...somatostatin analogs ~~~
  2. ...somatostatin analogs and the newer growth hormone receptor antagonist Pegvisomant (Trainer et al. 2000). MEN1-associated PIT were considered more aggressive than sporadic PIT, and more often unresponsive to medical treatment (especially in prolactinomas) necessitating earlier surgery (O’Brien et  al ~~~
  3. ...somatostatin analogs (SSAs; octreotide or lanreotide) for the control of GH over-secretion is reserved for second line therapy or for patients not eligible for surgery. Gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs) GEP-NETs clinically affect 30–80% of MEN1 patients, and 80–100% in postmo ~~~
  4. ...somatostatin analogs are used. Several studies on EUS have shown that it is the most sensitive imaging modality for the detection of dpNEN, especially of those smaller than 1 cm in size (van Asselt et  al. 2015, Kann et  al. 2006b). Kann and coworkers demonstrated that EUS is capable to identify MEN ~~~
  5. ...somatostatin analogs to everolimus and chemotherapy, local therapies (RFA, chemo-embolization, or radiotherapy) or peptide radio-receptor therapy (PRRT). In conclusion, there is currently no consensus available about the extent of resection in functional pNETs for patients with MEN1 and future studi ~~~
  6. ...somatostatin analogs ~~~
  7. ...somatostatin analogs (SSA) and somatostatin receptor ligands (SRL) to the growth hormone (GH) receptor antagonist pegvisomant and dopamine agonists (Melmed 2016). Radiotherapy techniques have undergone significant developments leading to the gamma-knife used today. Modern acromegaly therapy is guide ~~~
  8. ...somatostatin analogs era. It was evaluated the incidence of cancer in an Italian nationwide multicenter cohort study of 1512 acromegalic patients, 624 men and 249 495–504 Correspondence should be addressed to G Reimondo Email [email protected] Key Words f acromegaly f cancer f GH f IGF1 496 ~~~
  9. ...somatostatin analogs and everolimus can also decrease symptoms of hypersecretion and increase progression-free survival. Several factors affect the survival in patients with a functioning NET. Complications of hypersecretion negatively impact survival; however, secretion of hormones is also often a ~~~
  10. ...somatostatin analogs ~~~
For checked items